Evidence map›Paper›PMID 34821368›Full record

ArticleDisease models & mechanisms2021

Bi-phasic effect of gelatin in myogenesis and skeletal muscle regeneration.

Xiaoling Liu, Er Zu, Xinyu Chang, Xiaowei Ma, Ziqi Wang, Xintong Song, Xiangru Li, Qing Yu, Ken-Ichiro Kamei, Toshihiko Hayashi and 5 more

Open access · goldAbstract read
In one paragraph

Article in Disease models & mechanisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Xiaoling LiuWuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China.ORCID 0000-0002-1352-1003
Er ZuWuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China.ORCID 0000-0001-9046-0825
Xinyu ChangWuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China.ORCID 0000-0002-7035-5953
Xiaowei MaWuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China.ORCID 0000-0001-8212-5453
Ziqi WangSchool of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, China.ORCID 0000-0002-7558-1394
Xintong SongWuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China.ORCID 0000-0002-1689-717X
Xiangru LiSchool of Life Science and Biopharmaceutic, Shenyang Pharmaceutical University, Shenyang 110016, China.ORCID 0000-0003-1466-2884
Qing YuSchool of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, China.ORCID 0000-0001-9918-0192
Ken-Ichiro KameiWuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China.ORCID 0000-0003-2948-3264
Toshihiko HayashiWuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China.ORCID 0000-0002-2843-0948
Kazunori MizunoNippi Research Institute of Biomatrix, Toride, Ibaraki 302-0017, Japan.ORCID 0000-0003-3354-6264
Shunji HattoriNippi Research Institute of Biomatrix, Toride, Ibaraki 302-0017, Japan.ORCID 0000-0003-2816-4923
Hitomi FujisakiNippi Research Institute of Biomatrix, Toride, Ibaraki 302-0017, Japan.ORCID 0000-0002-8119-8543
Takashi IkejimaWuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China.ORCID 0000-0001-8202-9429
Dan Ohtan WangWuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China.ORCID 0000-0001-8302-5403
Shenyang Pharmaceutical University · CNJapan Institute of Leather Research · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skeletal muscle regeneration requires extracellular matrix (ECM) remodeling, including an acute and transient breakdown of collagen that produces gelatin. Although the physiological function of this process is unclear, it has inspired the application of gelatin to injured skeletal muscle for a potential pro-regenerative effect. Here, we investigated a bi-phasic effect of gelatin in skeletal muscle regeneration, mediated by the hormetic effects of reactive oxygen species (ROS). Low-dose gelatin stimulated ROS production from NADPH oxidase 2 (NOX2) and simultaneously upregulated the antioxidant system for cellular defense, reminiscent of the adaptive compensatory process during mild stress. This response triggered the release of the myokine IL-6, which stimulates myogenesis and facilitates muscle regeneration. By contrast, high-dose gelatin stimulated ROS overproduction from NOX2 and the mitochondrial chain complex, and ROS accumulation by suppressing the antioxidant system, triggering the release of TNFα, which inhibits myogenesis and regeneration. Our results have revealed a bi-phasic role of gelatin in regulating skeletal muscle repair mediated by intracellular ROS, the antioxidant system and cytokine (IL-6 and TNFα) signaling.

Indexed as

GelatinMuscle DevelopmentMuscle, SkeletalReactive Oxygen SpeciesRegenerationWound HealingGelatinReactive Oxygen SpeciesGelatinHormesisIL-6/TNFαNOX2ROSSkeletal muscle regeneration

Identifiers

PMID34821368
PMCPMC8713995
OpenAlexW3216479556

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.